Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Crossing the digital divide between big pharma and real-world patients

Can pharma harness the digital world?

- PMLiVE

Bluebird and Alexion veterans launch cell and gene venture ElevateBio

'Basecamp' will provide expertise and labs to launch multiple firms

Eli Lilly HQ

Lilly scores FDA okay for Cyramza in liver cancer

Approved as second line treatment after Bayer’s Nexavar

- PMLiVE

Grail’s multi-cancer blood test gets FDA breakthrough status

Could detect multiple cancers from single blood sample

- PMLiVE

Pfizer’s alliance with Sosei Heptares bears first fruit

Partners focusing on GPCR-targeting drugs

Porterhouse Medical Advisory Group

Deploying clinical experience and insight to gain maximum impact

Introducing the Porterhouse Medical Advisory Group (MAG)

Porterhouse Medical Group

- PMLiVE

The trials and tribulations of rare opportunities

Those hoping to follow where Humira, Soliris and Fabrazyme led should be prepared for clinical development to be complex

Healthcare communications in the mobile age

In the May issue of PME, Bluedog’s Matt Royle discusses the rapid evolution of the digital landscape and asks the question, are we keeping up?As a growing population of digital...

Lucid Group Communications Limited

- PMLiVE

New data backs Merck’s segue into MS with BTK inhibitor

Patients had fewer lesions on evobrutinib than placebo

Lucid Group’s cinematic performance at its company team briefing

The Electric Cinema on Portobello Road, London, played host to Lucid’s first new-look quarterly team briefing, during which all UK employees gathered. Dennis O’Brien (CEO) kicked off with a performance...

Lucid Group Communications Limited

- PMLiVE

UK heart deaths rise for first time in 50 years

Includes younger under 65s group

Teva Pharma logo

US states sue generic firms over ‘inflated’ prices

Companies accused of “multi-billion dollar fraud" and conspiracy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links